Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Obstr Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05832814
What this trial is testing

Music Therapy for COPD Rehabilitation

Who this might be right for
Chronic Obstructive Pulmonary Disease
China-Japan Friendship Hospital 75
Early research (Phase 1)Study completedNCT02666287
What this trial is testing

GSK961081 Alone and With Fluticasone Furoate (FF), Phase 1 (Ph1), Single Dose Regimen (SD), Repeat Dose Regimen (RD), Pharmacokinetic (PK) Study in Healthy Volunteer (HV)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 48
Early research (Phase 1)Study completedNCT00655993
What this trial is testing

Effect of Statin Therapy on C-reactive Protein Levels in Patients With Chronic Obstructive Lung Disease (COPD)

Who this might be right for
COPDInflammation
VA Loma Linda Health Care System 30
Not applicableNot Yet RecruitingNCT06105814
What this trial is testing

Improved Diagnostics, Treatment and Follow-up of Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease ExacerbationPneumoniaRespiratory Tract Infections
Vestre Viken Hospital Trust 200
Not applicableStudy completedNCT03583099
What this trial is testing

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 3)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Weill Medical College of Cornell University 2,004
Large-scale testing (Phase 3)Study completedNCT00239447
What this trial is testing

Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 131
Early research (Phase 1)Study completedNCT00085852
What this trial is testing

US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial Formulation

Who this might be right for
Pulmonary Emphysema
Aeris Therapeutics 6
Not applicableUnknownNCT05618847
What this trial is testing

Effects of Active Cycle of Breathing Technique With and Without Acapella on Airway Clearance

Who this might be right for
Chronic Obstructive Pulmonary Disease
Riphah International University 54
Post-approval studies (Phase 4)Study completedNCT04155047
What this trial is testing

A Clinical Study to Investigate if a Single Dose of an Approved Drug Product (Glycopyrrolate Inhalation Solution) Reduces Trapped Air in the Lungs of Participants With Chronic Obstructive Pulmonary Disease.

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Sunovion Respiratory Development Inc. 44
Testing effectiveness (Phase 2)Study completedNCT07132983
What this trial is testing

A Phase II Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Single Inhaled Doses of Ensifentrine-glycopyrrolate Fixed Dose Combination, Ensifentrine, and Glycopyrrolate in Subjects With Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease
Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA 33
Not applicableStudy completedNCT06321731
What this trial is testing

Real-World Outcomes in COPD Patients Starting Trixeo (Budesonide/Glycopyrronium/Formoterol) in Spain.

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 718
Post-approval studies (Phase 4)Study completedNCT01443845
What this trial is testing

Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)

Who this might be right for
COPDCOPD ExacerbationLung Diseases+4 more
AstraZeneca 2,354
Not applicableUnknownNCT02868983
What this trial is testing

Integrating Behavioral Health and Primary Care for Comorbid Behavioral and Medical Problems

Who this might be right for
ArthritisAsthmaChronic Obstructive Lung Disease+11 more
University of Vermont 4,025
Not applicableStudy completedNCT04709562
What this trial is testing

Clinical Stabilization of Hypercapnia: NIPPV v HVNI

Who this might be right for
Hypercapnic Respiratory FailureChronic Obstructive Pulmonary DiseaseDyspnea+1 more
Vapotherm, Inc. 68
Not applicableStudy completedNCT02001922
What this trial is testing

Soins intégrés BPCO (Broncho-pneumopathie Chronique Obstructive) en Valais - Mieux Vivre Avec ma BPCO (COPD Integrated Care Program Valais - Living Well With COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Centre Hospitalier du Centre du Valais 57
Post-approval studies (Phase 4)Study completedNCT03156231
What this trial is testing

Effect Of Acetazolamide On Altitude Related Illness In Patients With Respiratory Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
University of Zurich 185
Not applicableStudy completedNCT06663462
What this trial is testing

EzPAP Therapy Versus Non-invasive Ventilation Therapy

Who this might be right for
Non Invasive Ventilation
Kırklareli University 19
Not applicableEnded earlyNCT01526642
What this trial is testing

Home Non-invasive Ventilation for Chronic Obstructive Pulmonary Disease Patients

Who this might be right for
Chronic Obstructive Pulmonary DiseaseHypercapnic Respiratory Failure
University Hospital, Rouen 12
Not applicableStudy completedNCT01331694
What this trial is testing

Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 76,130
Testing effectiveness (Phase 2)Study completedNCT01566773
What this trial is testing

PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Pearl Therapeutics, Inc. 140
Next Page